EDGEMOND JAMES bought UTHR
November 17, 2025 · Form 4 insider transaction
EDGEMOND JAMES bought 10,688 shares of United Therapeutics Corporation at $146.03 per share, a transaction worth $1.56M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,688
Price
$146.03
Total value
$1.56M
InsiderEDGEMOND JAMES
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 17, 2025
Filing dateNovember 18, 2025
Shares owned after18,806
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 5, 2025.